The Competition and Markets Authority (CMA) will not refer the Welltower care home deals for a phase two investigation after accepting remedies offered. In May, Welltower offered to sell ‘a number of care home properties’ as part of remedies following the CMA’s phase one investigation into its purchase of more than 600 settings across the…
Membership Required
You must be a CM Subscriber to view this content.
Already have an account? Sign In
©2026 All rights reserved LaingBuisson
 will not refer the Welltower care home deals for a phase two investigation after accepting remedies offered.){kind=link}